BIOSGN Share Price Performance
SEK 43.00
-11.20 (-20.66%)
Price SEK 43.00
Share Pricen/a
Biosergen AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
BIOSGN Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Biosergen AB (publ) Key Details
About BIOSGN
- Founded
- 2004
- Employees
- 1
- CEO
- WebsiteView website
Biosergen AB (publ), a biotech company, develops antifungal products. Its lead product is BSG005, an antifungal drug candidate for the treatment of invasive fungal infections in immunocompromised patients, including AIDS, cancer, and transplant recipients. The company was founded in 2004 and is based in Solna, Sweden.
